Justin Brink

Role: Bellbrook Labs
Location: Madison, WI, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

About Justin Brink

As President of BellBrook Labs, I lead a high-growth life sciences company that delivers…

Experience

Bellbrook Labs
Present

Skills

Program Management
Immunoassays
Manufacturing
Biotechnology
Online Marketing
Goldmine
Social Media Marketing
Google Analytics
Research
Social Media
Linkedin
Twitter
Life Sciences
Proteomics
Product Launch
Blog Marketing
Quality Assurance
Microsoft Office
Inside Sales
Market Research
Lifesciences
Trade Shows
Google Adwords
Problem Solving
Coaching
Nanotechnology
Innovation
Business Strategy
Strategic Planning
Promotions
Product Development
Technology Transfer
Salesforce.com
Key Account Management
R&D

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@bellbrooklabs.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Bellbrook Labs

Biotechnology Research · 16 employees · Founded 2002 · Madison, Wisconsin, United States

BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company, we identify areas where there is a strong need but a significant technical hurdle, and then we develop a solution. Transcreener® Biochemical Assay Technology: Our proprietary Transcreener® HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. It relies on homogenous fluorescent immunodetection of nucleotides, including ADP, UDP, GDP, AMP and GMP, that are formed by thousands of cellular enzymes. Among these are group transferase families, such as kinases and glycosyltransferases, that catalyze the covalent regulatory reactions that are central to cell signaling. Each Transcreener Assay provides a generic detection method for multiple enzyme families. This means that you can focus on evaluating new therapeutic strategies and optimizing lead molecules rather than on time-consuming assay development for individual targets. The platform has been rapidly validated and adopted by pharmaceutical and biotechnology screening labs around the world.

bellbrooklabs.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.